Clinical Trial Update: Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the combination of Inotuzumab ozogamicin with lower-dose chemotherapy versus standard chemotherapy in adults with B-cell acute l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Lymphoblastic Lymphoma

Drugs mentioned

• Besponsa (inotuzumab ozogamicin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING